Vigilance medical devices

The responsibilities of Competent Authorities in terms of market vigilance are set out in the Articles of the device directives, whereas the obligations for manufacturers are contained in the Armexes. MEDDEV guide 2.12-1 provides detailed practical guidance on how the medical device vigilance system should operate within the EU, the European Economic Area (EEA) and Switzerland. This guidance was significantly... 

MEDDEV guide 2.12-1 Guidelines on a Medical Devices Vigilance System http //ec.europa.eu/enterprise/medicaLdevices/meddev/index.htm. 

Guidance is issued by the European Commission on medical device vigilance which includes an explanation of the difficult concept of when a deterioration in state of health should be considered serious ... 

The Medical Devices Vigilance System European Commission Guidelines, Medical Devices Agency, undated. 

The requirements for market vigilance and oversight in the US are set out in 21 CFR 803, Medical Device Reporting, 21 CFR 806, Reports of Corrections and Removals and 21 CFR 822 Post market Surveillance. 

Active Implantable Medical Devices Directive 90/385 EEC Article 8 (Competent Authority Vigilance procedure), Annex II 3.1 (manufacturer s vigilance and reporting duties)... 

The duties of EU manufacturers with respect to adverse-event notification and evaluation have been regulated in the Product Safety Directives, but for the operation of a vigilance system to enhance patient safety, there are only guidelines and no law. In practice, this means that EU manufacturers are obliged to notify any adverse event to the competent authority of their country (e.g., the medical device agency of the National Health Inspectorate). The... 

---